Datapharma Australia
  • Home
  • About
    • Team
      • Company History
    • Testimonials
      • International Friends
  • Services
    • Clinical Trial Design
    • Clinical Trial Management
    • Clinical Trial Monitoring Services
    • CRF Design and Data Capture
    • Data Management Services
    • Medical and Scientific Writing Services
    • Medical Monitoring
    • Pharmacovigilance Services
    • Quality Control Processes and Auditing
    • Statistics Services for Clinical Trials
    • Statistics in Clinical Trial Preparation
    • Data Conversion
    • Statistical Analysis
  • Therapeutic Experience
    • Oncology Clinical Trials
    • Respiratory Clinical Trials
    • Cardiovascular Clinical Trials
    • Pain Clinical Trials
    • Neurological Clinical Trials
    • Dermatology Clinical Trials
    • Gastroenterology Clinical Trials
    • Metabolic Clinical Trials
    • Early Phase Clinical Trials
    • Late Phase Clinical Trials
  • Blog
  • Training & Courses
    • Introduction to Clinical Research Course
    • GCP Refresher Course
    • Sponsor Responsibilities in Non-commercial Trials
  • Contact
Menu
  • Home
  • About
    • Team
      • Company History
    • Testimonials
      • International Friends
  • Services
    • Clinical Trial Design
    • Clinical Trial Management
    • Clinical Trial Monitoring Services
    • CRF Design and Data Capture
    • Data Management Services
    • Medical and Scientific Writing Services
    • Medical Monitoring
    • Pharmacovigilance Services
    • Quality Control Processes and Auditing
    • Statistics Services for Clinical Trials
    • Statistics in Clinical Trial Preparation
    • Data Conversion
    • Statistical Analysis
  • Therapeutic Experience
    • Oncology Clinical Trials
    • Respiratory Clinical Trials
    • Cardiovascular Clinical Trials
    • Pain Clinical Trials
    • Neurological Clinical Trials
    • Dermatology Clinical Trials
    • Gastroenterology Clinical Trials
    • Metabolic Clinical Trials
    • Early Phase Clinical Trials
    • Late Phase Clinical Trials
  • Blog
  • Training & Courses
    • Introduction to Clinical Research Course
    • GCP Refresher Course
    • Sponsor Responsibilities in Non-commercial Trials
  • Contact
    Parkinson’s Awareness Month: Advancing Research and Building a Stronger Clinical Trials Network in Australia

    Parkinson’s Awareness Month: Advancing Research and Building a Stronger Clinical Trials Network in Australia

    April is Parkinson’s Awareness Month—a time to shine a light on one of the fastest growing neurological conditions in the world. At Datapharm, we are proud to support ongoing efforts to improve the...
    Continue Reading
    ICH GCP E6(R3) Update – What the Latest Version Means for Clinical Trials and Ethical Compliance

    ICH GCP E6(R3) Update – What the Latest Version Means for Clinical Trials and Ethical Compliance

    In the realm of clinical research, ethical oversight and scientific integrity are paramount. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use...
    Continue Reading
    Literature Search Strategies in Pharmacovigilance for Post-Marketing/Approved Medicines

    Literature Search Strategies in Pharmacovigilance for Post-Marketing/Approved Medicines

    Data obtained from the medical and scientific literature is a key aspect of monitoring the safety profile and risk-benefit balance of medicines, as it can help identify new safety signals or safety...
    Continue Reading
    Australian Cancer Research Oncology Clinical Trial Site Tour

    Australian Cancer Research Oncology Clinical Trial Site Tour

    Conducting cancer clinical trials in Australia involves a comprehensive and structured approach, guided by stringent regulatory standards, ethical considerations, and a commitment to high-quality...
    Continue Reading
    2024 Update to the Declaration of Helsinki – Relevance for Clinical Trials and Ethical Standards

    2024 Update to the Declaration of Helsinki – Relevance for Clinical Trials and Ethical Standards

    The Declaration of Helsinki, the globally recognised foundation for ethical guidelines in medical research involving human participants, was updated in October 2024. This revision is important for...
    Continue Reading
    ICU Clinical Trials: Navigating Challenges in Critical Care Research

    ICU Clinical Trials: Navigating Challenges in Critical Care Research

    Clinical trials play a vital role in advancing medical knowledge and improving patient outcomes. However, conducting ICU clinical trials in an Intensive Care Unit (ICU) setting presents unique...
    Continue Reading
    The Role of Technology in Data Capture for Post-Marketing Studies

    The Role of Technology in Data Capture for Post-Marketing Studies

    Post-marketing studies, also known as Phase IV trials, are essential for evaluating the long-term safety and efficacy of drugs after they have received regulatory approval. These studies gather...
    Continue Reading
    Let’s Connect and Collaborate with Datapharm CRO at local 2024 conferences in Australia!

    Let’s Connect and Collaborate with Datapharm CRO at local 2024 conferences in Australia!

    Whether you’re attending PDC 2024, AusBioInvest 2024, AusBiotech National Conference 2024, or COSA ASM 2024, Datapharm Australia is excited to meet with you and explore how we can support your...
    Continue Reading
    Running Phase IV Clinical Trials in Australia: Key Insights and Benefits

    Running Phase IV Clinical Trials in Australia: Key Insights and Benefits

    Phase IV clinical trials, often referred to as late-phase or post-marketing studies, play a crucial role in the drug development lifecycle. In Australia, the significance of conducting these trials...
    Continue Reading
    Phase IIb Studies: Assessing Efficacy and Optimising Dosing in Clinical Trials

    Phase IIb Studies: Assessing Efficacy and Optimising Dosing in Clinical Trials

    As a leading Australian CRO, Datapharm Australia specialises in managing Phase IIb clinical trials, a critical stage in drug development focused on assessing efficacy, safety, and optimising dosage. ...
    Continue Reading
    SAD and MAD Studies in Early Phase Clinical Trials: Ensuring Drug Safety and Efficacy

    SAD and MAD Studies in Early Phase Clinical Trials: Ensuring Drug Safety and Efficacy

    As a leading Australian CRO, Datapharm Australia specialises in the critical early stages of clinical development, including Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) studies....
    Continue Reading
    Clinical Monitoring in Early Phase Clinical Trials: Ensuring Data Integrity and Patient Safety

    Clinical Monitoring in Early Phase Clinical Trials: Ensuring Data Integrity and Patient Safety

    Early-phase clinical trials, encompassing Phase I and Phase IIa studies, are critical steps in the drug development process. These trials aim to evaluate the safety, tolerability, and...
    Continue Reading
    • 1
    • 2
    • 3
    • 4
    • 5
    Menu
    • About
    • Services
    • Therapeutic Experience
    • Blog
    • Contact
    • Privacy Policy
    Copyright 2024 © Datapharm Australia